Endospan Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Employees
-
59
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$450M
Endospan General Information
Description
Developer of an aortic stent-grafts system designed to treat aneurysms, dissections and aortic lesions. The company's aortic stent-grafts system offers invasive endovascular services and differentiated aortic endografts to address underserved clinical needs and patients' subgroups, thereby enabling patients diagnosed with an aneurysm to get proper treatment.
Contact Information
Website
www.endospan.com(Operating Subsidiary)
Corporate Office
- Maskit Street 4
- Herzlia Business Park
- Herzliya 46733
- Israel
Corporate Office
- Maskit Street 4
- Herzlia Business Park
- Herzliya 46733
- Israel
Endospan Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 18-May-2026 | $450M | Completed | Generating Revenue | ||
| 2. Later Stage VC (Series B) | 21-Oct-2015 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 27-Sep-2011 | $15M | $15M | Completed | Generating Revenue |
Endospan Comparisons
Industry
Financing
Details
Endospan Competitors (10)
One of Endospan’s 10 competitors is Vesper Medical, a Formerly VC-backed company based in Wayne, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vesper Medical | Formerly VC-backed | Wayne, PA | ||||
| Elixir Medical | Venture Capital-Backed | Milpitas, CA | ||||
| ShockWave Medical | Formerly VC-backed | Santa Clara, CA | ||||
| Essential Medical | Formerly VC-backed | Exton, PA | ||||
| FLEX Vascular | Venture Capital-Backed | Plymouth, MN |
Endospan Patents
Endospan Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025196748-A1 | Double- and triple-branching ascending aortic stent-graft systems | Pending | 20-Mar-2024 | ||
| EP-4586970-A1 | Double-branching ascending aortic stent-graft systems | Pending | 15-Sep-2022 | ||
| US-20260090874-A1 | Double-branching ascending aortic stent-graft systems | Pending | 15-Sep-2022 | ||
| WO-2024057320-A1 | Double-branching ascending aortic stent-graft systems | Inactive | 15-Sep-2022 | ||
| EP-3600148-A1 | Stent-grafts for sealing around external disturbances | Active | 21-Mar-2017 | A61F2/07 |
Endospan Signals
Endospan Former Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Accelmed | Growth/Expansion | Minority | ||
| Arkin Capital | Asset Manager | Minority | ||
| Haisco Pharmaceutical Group Company | Corporation | Minority | ||
| Haisthera Scientific Fund | Corporation | Minority | ||
| SCP Vitalife Partners | Venture Capital | Minority |
Endospan FAQs
-
When was Endospan founded?
Endospan was founded in 2009.
-
Where is Endospan headquartered?
Endospan is headquartered in Herzliya, Israel.
-
What is the size of Endospan?
Endospan has 59 total employees.
-
What industry is Endospan in?
Endospan’s primary industry is Surgical Devices.
-
Is Endospan a private or public company?
Endospan is a Private company.
-
What is the current valuation of Endospan?
The current valuation of Endospan is .
-
What is Endospan’s current revenue?
The current revenue for Endospan is .
-
How much funding has Endospan raised over time?
Endospan has raised $25M.
-
Who are Endospan’s investors?
Accelmed, Arkin Capital, Haisco Pharmaceutical Group Company, Haisthera Scientific Fund, and SCP Vitalife Partners are 5 of 6 investors who have invested in Endospan.
-
Who are Endospan’s competitors?
Vesper Medical, Elixir Medical, ShockWave Medical, Essential Medical, and FLEX Vascular are some of the 10 competitors of Endospan.
-
When was Endospan acquired?
Endospan was acquired on 18-May-2026.
-
Who acquired Endospan?
Endospan was acquired by Artivion.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process